Vaxxinity, Inc. (the Issuer)
|
(b) |
Address of Issuers Principal Executive Offices: |
1717 Main St., Suite 3388, Dallas, Texas 75201.
(a) |
Name of Person Filing: |
This statement is filed by and on behalf of Mei Mei Hu (referred herein as the Reporting Person).
Pursuant to a voting agreement dated October 1, 2021, by and among various parties including the Reporting Person, the Reporting Persons spouse, United Biomedical, Inc. (UBI), and Blackfoot Healthcare Ventures
LLC (the Voting Agreement), the Reporting Person shall have the exclusive right to vote the shares of Class A Stock that are held by the Reporting Person, the Reporting Persons spouse, UBI and Blackfoot
Healthcare Ventures LLC (Blackfoot), in the Reporting Persons sole discretion, on all matters submitted to a vote of the stockholders of the Issuer. The Reporting Person disclaims beneficial ownership of the shares of
Class A Stock held directly by the Reporting Persons spouse, Blackfoot, UBI, and United Biomedical, Asia Inc.
The Reporting Person declares that none of the filing of this statement or anything herein or the Voting Agreement shall be
construed as an admission that the Reporting Person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person under the Voting Agreement
or otherwise) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding, or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a
member of any group with respect to the Issuer or any securities of the Issuer.
(b) |
Address of Principal Business Office or, if None, Residence: |
The address of the principal business office the Reporting Person is 1717 Main St., Suite 3388, Dallas, Texas 75201.
See Item 4 on the cover page(s) hereto.
(d) |
Title and Class of Securities: |
Class A Common Stock, par value $0.0001 per share (Class A Stock)
92244V104